OncoTrack
Feb 15, 2017
OncoTrack develops new biomarkers for colon cancer
OncoTrack, a public-private consortium supported by the Innovative Medicines Initiative (IMI) joint undertaking, has conducted one of Europe’s largest collaborative academic-industry research projects to develop and assess novel approaches for identification of new markers for colon cancer. Scientists from the OncoT...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
